Compared with the livers of patients with fatty liver, the livers of patients with NASH exhibit upregulated expression of neutrophil-recruiting chemokines, such as CXCL1 and their receptors (CXCR1 and CXCR2) [17]. The gene discussed is CXCR2; the disease is metabolic dysfunction-associated steatohepatitis.